Evestra’s business model is based on two value propositions.
- Vaginal ring products based on innovative drug delivery technology
- Novel steroidal products which address major unmet medical needs in women's healthcare such as endometriosis, fibroids, hormone replacement therapy and fertility control
Business Strategy
The Company intends to develop its innovative pipeline through Phase I/II clinical proof of concept followed by establishing asset-based, or strategic corporate partnerships. Evestra’s differentiated NCE’s products exhibit a high probability of success due to the known endocrine mechanism of action and favorable benefit/risk ratio of steroidal-based products.
© 2017 Evestra, Inc.
